Herbalife (NYSE:HLF) Price Target Raised to $17.00

Herbalife (NYSE:HLF) had its price objective boosted by research analysts at B. Riley from $16.00 to $17.00 in a report released on Thursday, Briefing.com reports. The brokerage presently has a “buy” rating on the stock. B. Riley’s price objective would suggest a potential upside of 38.66% from the stock’s current price.

Other equities analysts have also recently issued reports about the company. DA Davidson restated a “neutral” rating and set a $9.50 price target on shares of Herbalife in a report on Thursday, May 2nd. StockNews.com lowered Herbalife from a “buy” rating to a “hold” rating in a research report on Wednesday. Finally, Mizuho upped their target price on Herbalife from $10.00 to $11.00 and gave the stock a “neutral” rating in a research report on Friday, June 7th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $11.75.

Herbalife Stock Performance

Herbalife stock opened at $12.26 on Thursday. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 8.95 and a beta of 1.25. Herbalife has a 52-week low of $6.68 and a 52-week high of $19.48. The stock’s 50 day moving average price is $11.13 and its two-hundred day moving average price is $10.33.

Herbalife (NYSE:HLF) last posted its quarterly earnings results on Wednesday, May 1st. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. The firm had revenue of $1.30 billion for the quarter, compared to analysts’ expectations of $1.26 billion. Herbalife had a negative return on equity of 19.97% and a net margin of 2.70%. The company’s revenue for the quarter was up 3.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.54 EPS. On average, equities research analysts forecast that Herbalife will post 1.48 EPS for the current year.

Insider Activity at Herbalife

In other Herbalife news, Director Juan Miguel Mendoza bought 3,000 shares of the firm’s stock in a transaction dated Monday, May 6th. The stock was purchased at an average cost of $9.67 per share, with a total value of $29,010.00. Following the transaction, the director now directly owns 73,279 shares in the company, valued at approximately $708,607.93. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, Director Donal L. Mulligan purchased 30,000 shares of the business’s stock in a transaction dated Friday, May 3rd. The stock was bought at an average price of $9.65 per share, for a total transaction of $289,500.00. Following the purchase, the director now owns 60,000 shares of the company’s stock, valued at $579,000. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Juan Miguel Mendoza purchased 3,000 shares of the business’s stock in a transaction dated Monday, May 6th. The shares were purchased at an average price of $9.67 per share, with a total value of $29,010.00. Following the purchase, the director now directly owns 73,279 shares in the company, valued at approximately $708,607.93. The disclosure for this purchase can be found here. In the last three months, insiders purchased 42,500 shares of company stock valued at $418,485. 0.94% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. nVerses Capital LLC boosted its stake in Herbalife by 240.0% in the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock worth $53,000 after purchasing an additional 3,600 shares during the period. Van ECK Associates Corp boosted its stake in Herbalife by 10.3% in the 2nd quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock worth $90,000 after purchasing an additional 808 shares during the period. Iridian Asset Management LLC CT boosted its stake in Herbalife by 18.9% in the 2nd quarter. Iridian Asset Management LLC CT now owns 1,550,454 shares of the company’s stock worth $16,109,000 after purchasing an additional 246,616 shares during the period. Bank of New York Mellon Corp boosted its stake in Herbalife by 8.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 410,827 shares of the company’s stock worth $4,268,000 after purchasing an additional 31,137 shares during the period. Finally, SummerHaven Investment Management LLC boosted its stake in Herbalife by 2.6% in the 2nd quarter. SummerHaven Investment Management LLC now owns 58,409 shares of the company’s stock worth $607,000 after purchasing an additional 1,465 shares during the period.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.